Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased
Haitao Yang, Wen‐Juan Xiu, Jing‐Kun Liu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 7263-7275
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Zhilei Wang, Yuchen Li, Wenhao Liao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 90
Food-derived bioactive peptides with anti-hyperuricemic activity: A comprehensive review
Arshad Mehmood, Asra Iftikhar, Xiumin Chen
Food Chemistry (2024) Vol. 451, pp. 139444-139444
Closed Access | Times Cited: 24
Gut microbiota as a new target for hyperuricemia: A perspective from natural plant products
Ling Dong, Fengying Dong, Pingping Guo, et al.
Phytomedicine (2025) Vol. 138, pp. 156402-156402
Closed Access | Times Cited: 8
The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study
Haixiao Jiang, Wei Zeng, Xiaoli Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 7846-7858
Open Access | Times Cited: 49
Lactococcus cremoris D2022 alleviates hyperuricemia and suppresses renal inflammation via potential gut-kidney axis
Zhihuan Wang, Yuanming Huang, Tao Yang, et al.
Food & Function (2024) Vol. 15, Iss. 11, pp. 6015-6027
Closed Access | Times Cited: 9
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
Xinghong Wu, Chongge You
PeerJ (2022) Vol. 11, pp. e14554-e14554
Open Access | Times Cited: 36
The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment
Shuting Tong, Peiyu Zhang, Qi Cheng, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
Prediction and causal inference of hyperuricemia using gut microbiota
Yuna Miyajima, Shigehiro Karashima, Ren Mizoguchi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Study on the mechanism of Orthosiphon aristatus (Blume) Miq. in the treatment of hyperuricemia by microbiome combined with metabonomics
Chunsheng Zhu, Hongjuan Niu, Meng Bian, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116805-116805
Closed Access | Times Cited: 15
Limosilactobacillus reuteri HCS02-001 Attenuates Hyperuricemia through Gut Microbiota-Dependent Regulation of Uric Acid Biosynthesis and Excretion
Akbar Hussain, Binqi Rui, Hayan Ullah, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 637-637
Open Access | Times Cited: 5
Alterations in the gut microbiome and metabolism profiles reveal the possible molecular mechanism of renal injury induced by hyperuricemia in a mouse model of renal insufficiency
Ping Liu, Jianli Yang, Meiping Jin, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 5
The impact of short-chain fatty acid–producing bacteria of the gut microbiota in hyperuricemia and gout diagnosis
Gabriela Angélica Martínez‐Nava, Eder Orlando Méndez-Salazar, Janitzia Vázquez‐Mellado, et al.
Clinical Rheumatology (2022) Vol. 42, Iss. 1, pp. 203-214
Closed Access | Times Cited: 21
Lactiplantibacillus pentosus P2020 protects the hyperuricemia and renal inflammation in mice
Zhihuan Wang, Liqiong Song, Xianping Li, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 13
Lactobacillus gasseri LG08 and Leuconostoc mesenteroides LM58 exert preventive effect on the development of hyperuricemia by repairing antioxidant system and intestinal flora balance
Lizhen Liang, Zihui Meng, Fei Zhang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Gut Microbiome-Based Diagnostic Model to Predict Diabetes Mellitus
Haitao Yang, Jing‐Kun Liu, Wen‐Juan Xiu, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12521-12534
Open Access | Times Cited: 27
The human gut microbiota and uric acid metabolism: genes, metabolites, and diet
Lei Sun, Min Zhang, Jianxin Zhao, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-21
Closed Access
Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys
Ting Wang, Li Li, Liu Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Progress in oral biomaterials for the treatment of metabolic bone diseases
Yunkai Tang, Adilijiang Abudousu, Wenguo Cui
Progress in Materials Science (2025), pp. 101499-101499
Closed Access
Habitual coarse grain intake, gut microbiota, and hyperuricemia in individuals with or at risk of metabolic syndrome: A post-hoc analysis
Juan He, Yifei He, Junqi Li, et al.
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 104126-104126
Closed Access
Coix Seed Oil Alleviates Hyperuricemia in Mice by Ameliorating Oxidative Stress and Intestinal Microbial Composition
Guozhen Wu, Xinming Wang, Hongjing Dong, et al.
Nutrients (2025) Vol. 17, Iss. 10, pp. 1679-1679
Open Access
Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a systematic review
Salman Shirvani-Rad, Niloufar Khatibzade‐Nasari, Hanieh‐Sadat Ejtahed, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9
Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia
Ping Liu, Jianli Yang, Yu Chen, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e20328-e20328
Open Access | Times Cited: 9
Amelioration of hyperuricemia by Lactobacillus acidophilus F02 with uric acid-lowering ability via modulation of NLRP3 inflammasome and gut microbiota homeostasis
Yingping Meng, Yingsheng Hu, Min Wei, et al.
Journal of Functional Foods (2023) Vol. 111, pp. 105903-105903
Open Access | Times Cited: 9
Microbiota and arthritis: cause or consequence?
Giacomo Cafaro, Giulia Cruciani, Lorenza Bruno, et al.
Clinical and Experimental Rheumatology (2024)
Open Access | Times Cited: 3
Changes in gut microbiota structure and function in gout patients
Feiyan Zhao, Zhixin Zhao, Dafu Man, et al.
Food Bioscience (2023) Vol. 54, pp. 102912-102912
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top